Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Anele Romeo

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Virus Research|November 18, 2020
The cross-talk between STAT1/STAT3 and ROS up-regulates PD-L1 and promotes the release of pro-inflammatory/immune suppressive cytokines in primary monocytes infected by HHV-6BMaria Anele Romeo, Maria Saveria Gilardini Montani, Rossella Benedetti, et al.
International Journal of Molecular Sciences|August 26, 2022
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell LymphomasRossella Benedetti, Andrea Arena, Maria Anele Romeo, et al.
The Journal of General Virology|November 15, 2018
Impact of HHV-6A and HHV-6B lytic infection on autophagy and endoplasmic reticulum stressMaria Anele Romeo, Laura Masuelli, Aurelia Gaeta, et al.
Discover Oncology|March 31, 2023
NRF2 and STAT3: friends or foes in carcinogenesis?Andrea Arena, Maria Anele Romeo, Rossella Benedetti, et al.
Cellular Signalling|October 2, 2017
Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activationMarisa Granato, Maria Saveria Gilardini Montani, Maria Anele Romeo, et al.
Scientific Reports|October 14, 2017
Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagyMarisa Granato, Maria Anele Romeo, Mariangela Sara Tiano, et al.
Experimental Cell Research|October 15, 2021
Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53Maria Anele Romeo, Maria Saveria Gilardini Montani, Rossella Benedetti, et al.
Virology|January 8, 2019
STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activationRoberta Santarelli, Valentina Carillo, Maria Anele Romeo, et al.
International Journal of Cancer|June 20, 2020
KSHV dysregulates bulk macroautophagy, mitophagy and UPR to promote endothelial to mesenchymal transition and CCL2 release, key events in viral-driven sarcomagenesisRoberta Santarelli, Ana Maria Brindusa Arteni, Maria Saveria Gilardini Montani, et al.
Carcinogenesis|December 27, 2021
p62/SQSTM1 promotes mitophagy and activates the NRF2-mediated antioxidant and anti-inflammatory response restraining EBV-driven B lymphocyte proliferationMaria Saveria Gilardini Montani, Greta Tarquini, Roberta Santarelli, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Virus Research|November 18, 2020
The cross-talk between STAT1/STAT3 and ROS up-regulates PD-L1 and promotes the release of pro-inflammatory/immune suppressive cytokines in primary monocytes infected by HHV-6BMaria Anele Romeo, Maria Saveria Gilardini Montani, Rossella Benedetti, et al.
International Journal of Molecular Sciences|August 26, 2022
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell LymphomasRossella Benedetti, Andrea Arena, Maria Anele Romeo, et al.
The Journal of General Virology|November 15, 2018
Impact of HHV-6A and HHV-6B lytic infection on autophagy and endoplasmic reticulum stressMaria Anele Romeo, Laura Masuelli, Aurelia Gaeta, et al.
Discover Oncology|March 31, 2023
NRF2 and STAT3: friends or foes in carcinogenesis?Andrea Arena, Maria Anele Romeo, Rossella Benedetti, et al.
Cellular Signalling|October 2, 2017
Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activationMarisa Granato, Maria Saveria Gilardini Montani, Maria Anele Romeo, et al.
Scientific Reports|October 14, 2017
Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagyMarisa Granato, Maria Anele Romeo, Mariangela Sara Tiano, et al.
Experimental Cell Research|October 15, 2021
Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53Maria Anele Romeo, Maria Saveria Gilardini Montani, Rossella Benedetti, et al.
Virology|January 8, 2019
STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activationRoberta Santarelli, Valentina Carillo, Maria Anele Romeo, et al.
International Journal of Cancer|June 20, 2020
KSHV dysregulates bulk macroautophagy, mitophagy and UPR to promote endothelial to mesenchymal transition and CCL2 release, key events in viral-driven sarcomagenesisRoberta Santarelli, Ana Maria Brindusa Arteni, Maria Saveria Gilardini Montani, et al.
Carcinogenesis|December 27, 2021
p62/SQSTM1 promotes mitophagy and activates the NRF2-mediated antioxidant and anti-inflammatory response restraining EBV-driven B lymphocyte proliferationMaria Saveria Gilardini Montani, Greta Tarquini, Roberta Santarelli, et al.
Pageof 5